Fibroscan

Fibroscan is a specialised non-invasive ultrasound-based technique that measures liver stiffness to assess the degree of fibrosis or scarring in the liver, often caused by chronic hepatitis, fatty liver disease or long-term alcohol use. It works by sending a painless vibration through the liver tissue and measuring the speed at which it travels, since stiffer, more scarred liver tissue transmits the vibration faster. The test also estimates the amount of fat within the liver, useful for diagnosing and staging non-alcoholic fatty liver disease. Fibroscan has largely reduced the need for invasive liver biopsy in many patients being monitored for chronic liver disease.

Fibroscan is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Hepatology specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is 10-15 minutes. This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes No recovery time is required as the test is completely non-invasive and painless. Patients can resume all normal activities immediately after the scan. Results are typically available the same day and reviewed with the treating hepatologist.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

Fibroscan has a documented success rate of 90%+ accurate for fibrosis staging at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.